PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - DeFronzo, Ralph A.
TI  - Combining Empagliflozin and Linagliptin with Metformin Reduces HbA1c in Patients with T2DM
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 11--12
VI  - 14
IP  - 32
4099  - http://mdc.sagepub.com/content/14/32/11.short
4100  - http://mdc.sagepub.com/content/14/32/11.full
AB  - Combined empagliflozin and linagliptin as add-on therapy to metformin provided enhanced glucose-reducing efficacy when compared with either drug as monotherapy in individuals with type 2 diabetes mellitus, as discussed in this article.